Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma (vol 13, 1160144, 2023)
FRONTIERS IN ONCOLOGY(2023)
关键词
head and neck squamous cell carcinoma,antineoplastic agents,immunological,antibodies,Kaplan-Meier estimate,patient outcomes,real-world observational study,treatment patterns
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要